263 related articles for article (PubMed ID: 12394795)
1. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.
Neuenburg JK; Brodt HR; Herndier BG; Bickel M; Bacchetti P; Price RW; Grant RM; Schlote W
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):171-7. PubMed ID: 12394795
[TBL] [Abstract][Full Text] [Related]
2. Changing patterns in the neuropathogenesis of HIV during the HAART era.
Langford TD; Letendre SL; Larrea GJ; Masliah E
Brain Pathol; 2003 Apr; 13(2):195-210. PubMed ID: 12744473
[TBL] [Abstract][Full Text] [Related]
3. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
Welch K; Morse A;
AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
5. Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies.
Vago L; Bonetto S; Nebuloni M; Duca P; Carsana L; Zerbi P; D'Arminio-Monforte A
AIDS; 2002 Sep; 16(14):1925-8. PubMed ID: 12351952
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated neurological disorders: a guide to pharmacotherapy.
Tan IL; McArthur JC
CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
[TBL] [Abstract][Full Text] [Related]
7. HIV-1/AIDS neuropathology in a Canadian teaching centre.
Walsh K; Thompson W; Megyesi J; Wiley CA; Hammond R
Can J Neurol Sci; 2004 May; 31(2):235-41. PubMed ID: 15198450
[TBL] [Abstract][Full Text] [Related]
8. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
9. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.
Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ
AIDS; 1999 Jul; 13(10):1249-53. PubMed ID: 10416530
[TBL] [Abstract][Full Text] [Related]
10. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
11. [HIV and the central nervous system].
Moulignier A
Rev Neurol (Paris); 2006 Jan; 162(1):22-42. PubMed ID: 16446621
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
Tan IL; McArthur JC
Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
[No Abstract] [Full Text] [Related]
14. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
Baeuerle M; Schmitt-Haendle M; Taubald A; Mueller S; Walter H; Pfeiffer C; Manger B; Harrer T
Eur J Med Res; 2005 Jul; 10(7):309-16. PubMed ID: 16055403
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].
Braicks O; Anneken K; Reichelt D; Schäbitz WR; Dziewas R; Evers S; Husstedt IW
Nervenarzt; 2011 Oct; 82(10):1290-5. PubMed ID: 21567297
[TBL] [Abstract][Full Text] [Related]
16. The changing pattern of HIV neuropathology in the HAART era.
Gray F; Chrétien F; Vallat-Decouvelaere AV; Scaravilli F
J Neuropathol Exp Neurol; 2003 May; 62(5):429-40. PubMed ID: 12769183
[TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral therapy on cognitive processing in HIV infection: cross-sectional and longitudinal studies of event-related potentials.
Husstedt IW; Frohne L; Böckenholt S; Frese A; Rahmann A; Heese C; Reichelt D; Evers S
AIDS Res Hum Retroviruses; 2002 May; 18(7):485-90. PubMed ID: 12015901
[TBL] [Abstract][Full Text] [Related]
18. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
[TBL] [Abstract][Full Text] [Related]
19. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience.
Oliveira JF; Greco DB; Oliveira GC; Christo PP; Guimarães MD; Oliveira RC
Rev Soc Bras Med Trop; 2006; 39(2):146-51. PubMed ID: 16699639
[TBL] [Abstract][Full Text] [Related]
20. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.
Patel K; Ming X; Williams PL; Robertson KR; Oleske JM; Seage GR;
AIDS; 2009 Sep; 23(14):1893-901. PubMed ID: 19644348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
